Strategic collaborations between pharmaceutical companies, clinical research organizations, and specialized supply partners. Expansion of pharmaceutical-grade active pharmaceutical ingredients (APIs) and novel cannabinoid molecules that enable more rigorous scientific exploration and formal drug development.
read more..